Immunosuppressive activity of lymphocyte mitogenesis by breast cancer-associated p43

Neoplasma

Volumn 43, Issue 6, 1996, Pages 363-366

  Reinerova M ^a   Veselovska Z ^a   Ausch, C ^b   Rosen, H R ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

breast cancer; concanavalin A; immunosuppression; lymphocyte cultures; p43

Indexed keywords

CONCANAVALIN A; ISOFERRITIN; PROTEIN P43; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; MITOGENESIS;

EID: 0029951691     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. CORTY, P.E., BRANDO, C., SHEVACH, E.M.: CD59 functions as a signal-transducing molecule for human T cell activation. J. Immunol., 146, 1991, 4092-4096.
2. HANN, H.W.L., STAHLHUT, M.W., CHUNG, L.: Inhibitory effects of isoferritins from tumour and non-tumour tissue on E-rosettes formation. Lancet, 1, 1984, 43-44.
3. HALVORSEN, R., GAUDERNACK, G., LEIVESTAD, T., VARIDAL, F., THORSBY, E.: Activation of resting pure CD4 and CD8 cells via CD3. Requirements for second signals. Scand. J. Immunol., 26, 1987, 197-202.
4. HALVORSEN, R., LEIVESTAD, T., GAUDERNACK, G., THORSBY, E.: Accessory cell dependent T cell activation via Ti/CD3; involvement of CD2-LFA3 interactions. Scand. J. Immunol., 28, 1988, 277-283.
5. HUNING, T., TIEFENTHALER, G., MEYER ZUM BUSCHENFELDE, K.H., MEUER, S.C.: Alternative pathway activation of T cells by binding of CD2 to its cell surface ligand. Nature, 326, 1987, 288-291.
6. KELLER, E.K., TOACHIM, H.L., PEARSE, T., SILETTI, D.M.: Decreased T-lymphocytes in patients with mammary cancer. Am. J. Clin. Pathol., 65, 1976, 445-449.
7. MAYMON, R., BAHARI, C., MOROZ, C.: Placental isoferritin measured by a specific monoclonal antibody as a new predictive marker for premature contractions. Obstet. Gynecol., 74, 1989, 597-599.
8. MEUER, S.C., MEYER ZUM BUSCHENFELDE, K.H.: T cell receptor triggering induces responsiveness to interleukin 1 and interleukin 2 but does not lead to T cell proliferation. J. Immunol., 136, 1986, 4106-4110.
9. MOROZ, C., GILER, S.H., KUPFER, B., URCA, I.: Lymphocytes bearing surface ferritin in patients with Hodgkin's disease and breast cancer. N. Engl. J. Med., 298, 1977, 1175-1176.
10. MOROZ, C., KUPFER, B., TWIG, S., PARHAMI-SEREN, B.: Preparation and characterization of monoclonal antibodies specific to placenta ferritin. Clin. Chim. Acta, 148, 1985, 111-115.
11. MOROZ, C., BESSLER, H.: Ferritin as a marker in malignancy. In: Iron in Immunity, Cancer and Inflammation. Eds: De Sousa, M., Brock, J. New York, Wiley 1989, 283-301.
12. MOROZ, C., KAHN, M., RON;, E.: The use of oncofetal ferritin-bearing lymphocytes as a marker for the cofetal ferritin-bearing lymphocytes as a marker for the screening, diagnosis, and follow-up patients with early breast malignancies. Screening of 3400 women. Cancer, 64, 1989, 691-697.
13. MOROZ, C., SHTERMAN, N., KUPFER, B.: T-cell mitogenesis stimulates the appearance of a new mRNA species coding for a 43 kDa peptide reactive with CM-H-9 monoclonal antibody specific for placental isoferritin. Proc. Natl. Acad. Sci., 86, 1989, 3282-3285.
14. MOROZ, C., BESSLER, H.: Ferritin as a marker in malignancy. In: Iron in Immunity, Cancer and Inflammation. Eds: De Sousa, M., Brock, J. New York, Wiley 1989, 283-301.
15. ROSEN, H.R., STIERER, M., GOTTLICHER, J., WOLF, H., WEBER, R., VOGL, E., EIBL, M.: Determination of placental ferritin (PLF)-positive lymphocytes in women in early stages of breast cancer. Int. J. Cancer, 52, 1992, 229-233.
16. ROSEN, H.R., MOROZ, C., REINER, A., REINEROVA, M., STIERER, M., ŠVEC, J., SCHEMPER, M., JAKESZ, R.: Expression of placental isoferritin (PLF)-associated p43 correlates with features of high differentiation in breast cancer. Breast Cancer Res. Treat., 24, 1992, 17-26.
17. SEDLÁK, J., REINEROVÁ, M., HUNÁKOVÁ, L., AUSCH, C., CHORVÁTH, B., ROSEN, H., MOROZ, C.: Alterations of cell surface antigens induced by placental isoform of ferritin in human carcinoma cell lines. Cancer Lett., 94, 1995, 101-106.
18. WHITEHEAD, R.H., ROBERTS, G.P., THATCHER, J., TEASDALE, C., HUGHS, L.E.: Masking of receptors for sheep erythrocytes on human T-lymphocytes by sera from breast cancer patients. J. Natl. Cancer Inst., 58, 1977, 1573-1577.